Deutsche Bank’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $264K | Buy |
+9,615
| New | +$262K | ﹤0.01% | 3107 |
|
|
2021
Q2 | – | Sell |
-1,724
| Closed | -$96K | – | 4591 |
|
|
2021
Q1 | $96K | Sell |
1,724
-156
| -8% | -$10.3K | ﹤0.01% | 3996 |
|
|
2020
Q4 | $137K | Buy |
1,880
+55
| +3% | +$6.45K | ﹤0.01% | 3668 |
|
|
2020
Q3 | $361K | Buy |
1,825
+281
| +18% | +$70.8K | ﹤0.01% | 2834 |
|
|
2020
Q2 | $432K | Sell |
1,544
-2,721
| -64% | -$635K | ﹤0.01% | 2729 |
|
|
2020
Q1 | $758K | Sell |
4,265
-1,396
| -25% | -$299K | ﹤0.01% | 2247 |
|
|
2019
Q4 | $1.39M | Sell |
5,661
-6,376
| -53% | -$1.17M | ﹤0.01% | 2185 |
|
|
2019
Q3 | $1.42M | Sell |
12,037
-5,363
| -31% | -$811K | ﹤0.01% | 2117 |
|
|
2019
Q2 | $2.82M | Buy |
17,400
+11,604
| +200% | +$2.21M | ﹤0.01% | 2170 |
|
|
2019
Q1 | $1.37M | Buy |
5,796
+1,245
| +27% | +$315K | ﹤0.01% | 2773 |
|
|
2018
Q4 | $1.23M | Sell |
4,551
-984
| -18% | -$285K | ﹤0.01% | 2734 |
|
|
2018
Q3 | $2.47M | Sell |
5,535
-38
| -0.7% | -$17.8K | ﹤0.01% | 2718 |
|
|
2018
Q2 | $2.62M | Buy |
5,573
+3,338
| +149% | +$1.77M | ﹤0.01% | 2781 |
|
|
2018
Q1 | $1.32M | Sell |
2,235
-724
| -24% | -$449K | ﹤0.01% | 3146 |
|
|
2017
Q4 | $1.6M | Sell |
2,959
-1,830
| -38% | -$828K | ﹤0.01% | 2884 |
|
|
2017
Q3 | $2M | Buy |
4,789
+542
| +13% | +$166K | ﹤0.01% | 2541 |
|
|
2017
Q2 | $1.05M | Buy |
4,247
+3,414
| +410% | +$961K | ﹤0.01% | 3001 |
|
|
2017
Q1 | $254K | Buy |
833
+50
| +6% | +$12.3K | ﹤0.01% | 3462 |
|
|
2016
Q4 | $114K | Buy |
+783
| New | +$116K | ﹤0.01% | 4007 |
|
|
2016
Q3 | – | Sell |
-1,381
| Closed | -$91K | – | 4898 |
|
|
2016
Q2 | $91K | Buy |
1,381
+148
| +12% | +$9.7K | ﹤0.01% | 4156 |
|
|
2016
Q1 | $73K | Buy |
1,233
+836
| +211% | +$55.9K | ﹤0.01% | 4173 |
|
|
2015
Q4 | $35K | Buy |
397
+67
| +20% | +$7.3K | ﹤0.01% | 4563 |
|
|
2015
Q3 | $37K | Buy |
330
+43
| +15% | +$7.56K | ﹤0.01% | 4559 |
|
|
2015
Q2 | $66K | Buy |
+287
| New | +$55.4K | ﹤0.01% | 4453 |
|
|
2014
Q2 | – | Sell |
-1,441
| Closed | -$109K | – | 5869 |
|
|
2014
Q1 | $109K | Sell |
1,441
-1,444
| -50% | -$225K | ﹤0.01% | 4191 |
|
|
2013
Q4 | $659K | Sell |
2,885
-5,145
| -64% | -$937K | ﹤0.01% | 2910 |
|
|
2013
Q3 | $1.39M | Sell |
8,030
-1,605
| -17% | -$246K | ﹤0.01% | 2711 |
|
|
2013
Q2 | $1.38M | Buy |
+9,635
| New | +$1.51M | ﹤0.01% | 2467 |
|
Other funds holding ASMB
Deutsche Bank's ASMB Position: Q2 2026 in Review
Deutsche Bank opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 9,615 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #3107 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ASMB as recently as Q1 2021.
Deutsche Bank first reported a position in ASMB in Q2 2013 and has held it in 28 quarters since. The position peaked at $2.82M in Q2 2019. 92 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.
- Deutsche Bank held 9,615 shares of Assembly Biosciences worth $264K as of Q2 2026.
- Assembly Biosciences was a new Deutsche Bank position in Q2 2026.
- Assembly Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3107 holding.
- Deutsche Bank first reported a position in Assembly Biosciences in Q2 2013 and has held it in 28 quarters since.
- Deutsche Bank's Assembly Biosciences position peaked at $2.82M in Q2 2019.
- 92 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.